Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research progress on the relationship between Paneth cells-susceptibility genes, intestinal microecology and inflammatory bowel disease. | World J Clin Cases | 2023 | 38130785 | PubTator, text mining | PubMed |
| Personalized Treatment for Crohn's Disease: Current Approaches and Future Directions. | Clin Exp Gastroenterol | 2023 | 38111516 | PubTator, text mining | PubMed |
| Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies. | Cell Rep Med | 2023 | 38086380 | PubTator, text mining | PubMed |
| Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis. | Int J Mol Sci | 2023 | 38068961 | PubTator, text mining | PubMed |
| Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factors. | J Gen Virol | 2023 | 38063292 | PubTator, text mining | PubMed |
| Small molecule modulators of immune pattern recognition receptors. | RSC Chem Biol | 2023 | 38033733 | PubTator, text mining | PubMed |
| Integrated systems biology approach identifies gene targets for endothelial dysfunction. | Mol Syst Biol | 2023 | 38031960 | PubTator, text mining | PubMed |
| Genetic Polymorphisms Involved in Bladder Cancer: A Global Review. | Oncol Rev | 2023 | 38025894 | PubTator, text mining | PubMed |
| The pathogenesis and potential therapeutic targets in sepsis. | MedComm (2020) | 2023 | 38020710 | PubTator, text mining | PubMed |
| OTUD1 ameliorates cerebral ischemic injury through inhibiting inflammation by disrupting K63-linked deubiquitination of RIP2. | J Neuroinflammation | 2023 | 38012669 | PubTator, text mining | PubMed |
| PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas. | Int J Mol Sci | 2023 | 38003535 | PubTator, text mining | PubMed |
| Resveratrol and Its Derivatives in Inflammatory Skin Disorders-Atopic Dermatitis and Psoriasis: A Review. | Antioxidants (Basel) | 2023 | 38001807 | PubTator, text mining | PubMed |
| The Anti-Oxidative, Anti-Inflammatory, Anti-Apoptotic, and Anti-Necroptotic Role of Zinc in COVID-19 and Sepsis. | Antioxidants (Basel) | 2023 | 38001795 | PubTator, text mining | PubMed |
| Nod1-dependent NF-kB activation initiates hematopoietic stem cell specification in response to small Rho GTPases. | Nat Commun | 2023 | 37996457 | PubTator, text mining | PubMed |
| Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectives. | Clin Transl Med | 2023 | 37983927 | PubTator, text mining | PubMed |
| Natural Products-Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry. | Molecules | 2023 | 37959859 | PubTator, text mining | PubMed |
| The role of oral microbiota in cancer. | Front Microbiol | 2023 | 37954233 | PubTator, text mining | PubMed |
| Mechanisms and biomarkers of immune-related adverse events in gastric cancer. | Eur J Med Res | 2023 | 37936161 | PubTator, text mining | PubMed |
| Dominant negative variants in KIF5B cause osteogenesis imperfecta via down regulation of mTOR signaling. | PLoS Genet | 2023 | 37934770 | PubTator, text mining | PubMed |
| State-of-the-art polyetheretherketone three-dimensional printing and multifunctional modification for dental implants. | Front Bioeng Biotechnol | 2023 | 37929192 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=9